Burden of seasonal influenza in children with neurodevelopmental conditions

Pediatric Infectious Disease Journal

Volumn 33, Issue 7, 2014, Pages 710-714

  Burton, Catherine ^a   Vaudry, W ^o   Moore, Dorothy ^b,h   Bettinger, Julie A ^c   Tran, Dat ^d,k   Halperin, Scott A ^e   Scheifele, David W ^c   Morris, R ^f   Dery P ^g   Lebel, M ⁱ   Le Saux, N ^j   Ford Jones, L ^k   Embree, J ^l   Law, B ^l   Tan, B ^m   Jadavji, T ⁿ   Sauve L ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f New Janeway Childrens Health and Rehabilitation Centre   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h MONTREAL CHILDREN S HOSPITAL   (Canada)

ⁱ UNIVERSITY OF MONTREAL   (Canada)

^j CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^k HOSPITAL FOR SICK CHILDREN   (Canada)

^l CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

^m ROYAL UNIVERSITY HOSPITAL   (Canada)

ⁿ ALBERTA CHILDREN'S HOSPITAL   (Canada)

^o STOLLERY CHILDREN S HOSPITAL   (Canada)

more..

Author keywords

children; developmental disabilities; influenza; nervous system diseases; seizures

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE;

ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILDHOOD MORTALITY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DRUG INDICATION; FEBRILE CONVULSION; HOSPITALIZED CHILD; HUMAN; IMMUNIZATION; INFECTION RISK; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; SEASONAL INFLUENZA; SEIZURE; ADOLESCENT; CANADA; COMPLICATION; FEMALE; INFANT; INFLUENZA, HUMAN; INTELLECTUAL IMPAIRMENT; MALE; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SEIZURES; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; INTELLECTUAL DISABILITY; MALE; PREVALENCE; RESPIRATION, ARTIFICIAL; SEIZURES;

EID: 84902477608     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000272     Document Type: Article

References (20)

1. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118:2409-2417.
2. Coffin SE, Zaoutis TE, Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with communityacquired influenza. Pediatrics. 2007;119:740-748.
3. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150:306-310.
4. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA. 2005;294:2188-2194.
5. National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2013-2014. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2013;39(ACS-4):1-37.
6. Tran D, Vaudry W, Moore DL, et al.; IMPACT investigators. Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004- 2009. Pediatrics. 2012;130:397-406.
7. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2008;34(ACS-3):1-46.
8. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2004;30(ACS-3):1-32.
9. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2005;31(ACS-6):1-32
10. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2006;32(ACS-7):1-28
11. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2007;33(ACS-7):1-38
12. Kwong KL, Lam SY, Que TL, et al. Influenza A and febrile seizures in childhood. Pediatr Neurol. 2006;35:395-399.
13. Chiu SS, Tse CY, Lau YL, et al. Influenza A infection is an important cause of febrile seizures. Pediatrics. 2001;108:E63.
14. Glaser CA, Winter K, DuBray K, et al. A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. Clin Infect Dis. 2012;55:514-520.
15. Blanton L, Peacock G, Cox C, et al. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics. 2012;130:390-396.
16. Cox CM, Blanton L, Dhara R, et al. 2009 pandemic influenza A (H1N1) deaths among children-United States 2009-2010. Clin Infect Dis 2011: 52(suppl 1):S69-S74.
17. Bhat N, Wright JG, Broder KR, et al.; Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-2567.
18. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59(RR-8):1-62.
19. Smith MJ, McFalls D, Hendricks J, et al. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions - United States, 2011-12 Influenza Season. MMWR 2013; 62:744-746.
20. Aoki F, Allen U, Stiver G, et al. The use of antiviral drugs for influenza: A foundation document for practitioners. Can J Infect Dis. 2013;24:supSC.